Results 211 to 220 of about 44,840 (262)

Experimental glycopeptide antibiotic EVG7 prevents recurrent Clostridioides difficile infection by sparing members of the Lachnospiraceae family. [PDF]

Nat Commun
Mons E, Henderickx JGE, Sanders IMJG, Rader AG, Perkins CE, Stel FM, van Groesen E, Smits WK, Theriot CM, Martin NI.   +9 more
europepmc   +1 more source

Oral Vancomycin for Prevention of Recurrent Clostridioides difficile Infection: A Randomized Clinical Trial.

JAMA Netw Open
Keating JA, Xu T, Graham MB, Ramesh M, Khanna S, Dixon J, Kates A, Haight K, Zhao J, Saddler C, Safdar N.   +10 more
europepmc   +1 more source

Neutropenic Fever Secondary to Concurrent Clostridioides difficile Infection and Neutropenic Enterocolitis. [PDF]

Cureus
Wiggins B, Sullivan JM, Banno F, Knight K, Rigby M, Minaudo M.   +5 more
europepmc   +1 more source

Correction: Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States. [PDF]

Infect Dis Ther
Wilson M, Golan Y, Nguyen D, Yazdani M, Amin AN.   +4 more
europepmc   +1 more source

Incidence of Clostridioides difficile Infections across Acute Care, Long-Term Acute Care, and Rehabilitation Facilities during the COVID-19 Pandemic in Los Angeles County, California

Rose Kottapalli
openalex   +1 more source